Tom K. Email & Phone Number

Boston, Ma, Us

United States

Extensive experience in BMT and GVHD at top Transplant Centers in the US, as well as, Breast, Colon, MPN’s, Lymphoma and CAR-T., Rare Blood Cancers, including Cholangiocarcinoma and Oncolytic Dermatology Launch Experience as well. In addition, Collaborative and relationship driven success that has created explosive sales and success, as well as, significant positive outcomes for patients. Award winning approach to sales and advancing patient care in a competitive marketplace.

Greater Boston Area

2018, 2019, 2020-President’s Club Winner! Oncology Territory Business Manager responsible for driving sales and increasing revenues in targeted Oncology/Hematology accounts throughout Boston at Harvard, Tufts & Boston University teaching hospitals. With expert experience in Rare Blood Diseases, GVHD, Breast, Colon, Skin, Liver. Increased sales by 2 million in one year for orphan drug in MPN arena. Extensive experience launching new biologicals in marketplace and meeting and exceeding goal. Extensive experience in solid & liquid tumors, managed care, clinical trial recruitment and Implementation, buy and bill and oral adherence programs.

2008 President’s Club Winner! Responsible for the Sales and Marketing of pharmaceutical prescription products to the Oncology community in the Greater Boston Area with respect to Harvard, Tufts and Boston University Medical Schools. Directly selling Chemotherapy and supportive care products to an expert audience of providers that dictate a medical course of action. Significant Experience in Breast, Colon, Lung, Skin, CINV, RINV, PONV. Buy& Bill. KOL's, Clinical Trials, IT's, etc.Presidents Club Award Winner 5XSpecial Achievement Award WinnerLaunched numerous new drugs in Oncology for first in class and for both solid tumors and supportive care disease states.Expert in Reimbursement and Specialty Care Pharmacy's.Extensive experience with Buy& Bill and infused chemo agents.Experience with Surgical Oncology, Moh's Dermatological procedures, Breast, Colon and Skin Cancers.

Sold and marketed anti-virals to a broad spectrum of physicians that treated Hiv/Aids and Hepatitis C.Launched new protease inhibitors for treatment of Hiv/Aids andCytomeglovirus.